Open AccessShort bevacizumab infusion as an effective and safe treatment for colorectal cancer
Author(s) -
Koichi Taira,
Satoshi Okazaki,
Akiyoshi Kasuga,
Haruhiko Machida,
Takashi Ikeya,
Aya Kimura,
Atsushi Nakata,
Yuji Nadatani,
Masaki Ohminami,
Shusei Fukunaga,
Koji Otani,
Shuhei Hosomi,
Fumio Tanaka,
Noriko Kamata,
Yasuaki Nagami,
Yasuhiro Fujiwara
Publication year - 2022
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2022.2572
Subject(s) - bevacizumab , medicine , colorectal cancer , interquartile range , clinical endpoint , adverse effect , ovarian cancer , perforation , cancer , gastroenterology , surgery , chemotherapy , anesthesia , randomized controlled trial , materials science , punching , metallurgy